Tag Archives: STE

A Director at Steris is Exercising Options

Yesterday it was reported that a Director at Steris (STE – Research Report), David B. Lewis, exercised options to sell 3,133 STE shares at $32.34 a share, for a total transaction value of $522.1K. This is Lewis’ first transaction since

JMP Securities Believes Steris Corp (NYSE: STE) Won’t Stop Here

JMP Securities analyst David Turkaly reiterated a Buy rating on Steris Corp (STE – Research Report) yesterday and set a price target of $135. The company’s shares opened today at $120.54, close to its 52-week high of $123.50. Turkaly said:

Stephens Believes Steris Corp (NYSE: STE) Won’t Stop Here

Stephens analyst Chris Cooley reiterated a Buy rating on Steris Corp (STE – Research Report) yesterday and set a price target of $135. The company’s shares opened today at $120.54, close to its 52-week high of $123.50. According to TipRanks.com,

The Sr. VP, Gen Counsel, and Sec. of Steris Corp (NYSE: STE) is Selling Shares

Today, the Sr. VP, Gen Counsel, and Sec. of Steris Corp (STE – Research Report), John Adam Zangerle, sold shares of STE for $192.5K. Following John Adam Zangerle’s last STE Sell transaction on November 15, 2017, the stock climbed by

Steris Corp (STE) Received its Third Buy in a Row

After Stephens and KeyBanc gave Steris Corp (NYSE: STE) a Buy rating last month, the company received another Buy, this time from Northcoast Research. Analyst David Keiser reiterated a Buy rating on Steris Corp today and set a price target

Analysts’ Top Healthcare Picks: Steris Corp (STE), ProQR (PRQR)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Steris Corp (NYSE:STE) and ProQR (NASDAQ:PRQR) with bullish sentiments. Steris Corp (STE) KeyBanc analyst Matthew Mishan maintained a Buy rating on Steris